Surgical Science Sweden AB (publ) (SUS.ST)
SEK 154.5
(0.85%)
SEK 154.5
(0.85%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.7 Billion SEK | 1.14% |
| 2022 | 4.64 Billion SEK | 16.88% |
| 2021 | 3.97 Billion SEK | 742.34% |
| 2020 | 472.27 Million SEK | 3.52% |
| 2019 | 456.21 Million SEK | 357.77% |
| 2018 | 99.65 Million SEK | 0.75% |
| 2017 | 98.92 Million SEK | 55.29% |
| 2016 | 63.7 Million SEK | 16.45% |
| 2015 | 54.7 Million SEK | 10.88% |
| 2014 | 49.33 Million SEK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 4.96 Billion SEK | 0.08% |
| 2024 Q1 | 4.95 Billion SEK | 5.45% |
| 2023 Q4 | 4.7 Billion SEK | -4.42% |
| 2023 FY | 4.7 Billion SEK | 1.14% |
| 2023 Q1 | 4.66 Billion SEK | 0.41% |
| 2023 Q2 | 4.92 Billion SEK | 5.5% |
| 2023 Q3 | 4.92 Billion SEK | -0.11% |
| 2022 Q2 | 4.44 Billion SEK | 8.79% |
| 2022 Q4 | 4.64 Billion SEK | -3.61% |
| 2022 Q3 | 4.82 Billion SEK | 8.47% |
| 2022 Q1 | 4.08 Billion SEK | 2.76% |
| 2022 FY | 4.64 Billion SEK | 16.88% |
| 2021 Q2 | 961.8 Million SEK | -0.14% |
| 2021 Q3 | 3.8 Billion SEK | 295.09% |
| 2021 FY | 3.97 Billion SEK | 742.34% |
| 2021 Q4 | 3.97 Billion SEK | 4.69% |
| 2021 Q1 | 963.15 Million SEK | 103.94% |
| 2020 Q2 | 461.34 Million SEK | 0.45% |
| 2020 FY | 472.27 Million SEK | 3.52% |
| 2020 Q3 | 458.5 Million SEK | -0.62% |
| 2020 Q4 | 472.27 Million SEK | 3.0% |
| 2020 Q1 | 459.29 Million SEK | 0.68% |
| 2019 Q2 | 99.19 Million SEK | -1.82% |
| 2019 FY | 456.21 Million SEK | 357.77% |
| 2019 Q4 | 456.21 Million SEK | 0.56% |
| 2019 Q3 | 453.66 Million SEK | 357.34% |
| 2019 Q1 | 101.03 Million SEK | 1.38% |
| 2018 Q4 | 99.65 Million SEK | 9.76% |
| 2018 FY | 99.65 Million SEK | 0.75% |
| 2018 Q1 | 94.1 Million SEK | -4.87% |
| 2018 Q2 | 92.3 Million SEK | -1.91% |
| 2018 Q3 | 90.8 Million SEK | -1.63% |
| 2017 Q1 | 60.2 Million SEK | -5.49% |
| 2017 Q2 | 93.9 Million SEK | 55.98% |
| 2017 FY | 98.92 Million SEK | 55.29% |
| 2017 Q3 | 93.4 Million SEK | -0.53% |
| 2017 Q4 | 98.92 Million SEK | 5.91% |
| 2016 FY | 63.7 Million SEK | 16.45% |
| 2016 Q1 | - SEK | 0.0% |
| 2016 Q4 | 63.7 Million SEK | 0.0% |
| 2015 FY | 54.7 Million SEK | 10.88% |
| 2014 FY | 49.33 Million SEK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aino Health AB (publ) | 13.51 Million SEK | -34698.527% |
| Bonzun AB (publ) | 46.75 Million SEK | -9958.763% |
| Kontigo Care AB (publ) | 49.77 Million SEK | -9348.811% |
| Medhelp Care Aktiebolag (publ) | 63.75 Million SEK | -7276.279% |
| RaySearch Laboratories AB (publ) | 1.95 Billion SEK | -140.833% |